Tracking Tumors, Extending Lives
After diagnosing a patient with metastatic breast cancer, physicians routinely administer highly toxic chemotherapy drugs for months at a time, and then use an MRI or other imaging device to determine if tumors have shrunk or expanded. But changes in the size of a tumor may appear long after it becomes resistant to the administered drug. By the time such changes are detected and a new treatment regimen is applied, it may be too late to save the patient. The average survival time from diagnosis is just three years. Read More Here